Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson's disease: the APOKADO study.
J Neural Transm (Vienna)
; 130(11): 1463-1474, 2023 11.
Article
in En
| MEDLINE
| ID: mdl-36862190
Full text:
1
Database:
MEDLINE
Main subject:
Parkinson Disease
/
Apomorphine
Type of study:
Clinical_trials
/
Observational_studies
Limits:
Humans
Language:
En
Journal:
J Neural Transm (Vienna)
Year:
2023
Type:
Article
Affiliation country:
France